Definitive Contract 75D30126C21514
Award Date 9/22/26
Potential Completion Date 9/29/31
Potential Value $1.5M
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Ottsville, PA 18942, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Centers for Disease Control and Prevention awarded an $847,104 definitive contract to Lampire Biological Labs Inc. for red blood cells from horses, turkeys, and guinea pigs on September 22, 2023, under no set-aside.</p> <p>Place of performance is Ottsville, Pennsylvania. The contract is priced firm fixed price with an ultimate completion date of September 21, 2026.</p>
- This federal contract award was made by the Centers for Disease Control and Prevention (CDC) to Lampire Biological Labs Inc., a for-profit manufacturer specializing in custom antibodies, blood products, tissues, organs, and reagents. The $919,988 firm fixed price definitive contract is to supply red blood cells from horses, turkeys, and guinea pigs to the CDC's location in Pittsburgh, Pennsylvania over a performance period from September 22, 2023 to September 21, 2026. Lampire has also...
- This is a $148,500 firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Lampire Biological Labs Inc. for the provision of various animal blood products. The contract has a period of performance from August 1, 2016 to September 18, 2017 and does not utilize any set-aside designations. According to the information provided, Lampire Biological Labs Inc. is a for-profit manufacturer that specializes in custom antibodies, blood products, tissues,...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $4,888.00 firm fixed price purchase order to Lampire Biological Labs Inc., a for-profit manufacturer, to provide weekly shipments of red turkey blood cells for 52 weeks. This award was set aside for small businesses. Lampire Biological Labs Inc. is a manufacturer that specializes in custom antibodies, blood products, tissues, organs, and reagents for research,...
- This $3,315 firm fixed-price purchase order was awarded on December 30, 2015, to Lampire Biological Labs Inc. for a 52-week supply of lampire blood to support civilian research activities within the Plains Area agency through December 31, 2016. The contract was awarded without a set-aside designation, reflecting the contractor's competitive positioning in the specialized biological materials market. Lampire Biological Labs Inc., based in Ottsville, Pennsylvania, is a registered for-profit entity...
- The U.S. General Services Administration awarded a delivery order valued at $2,320.75 to Lampire Biological Labs Inc. for the supply of horse and sheep blood under the parent contract 123A9418D0003. The award was made without a set-aside designation on August 9, 2018, with a completion date of January 27, 2020. Performance was scheduled to take place in St. Louis, Missouri, and specific delivery amounts and dates were outlined in an attached schedule. The contract utilized firm fixed pricing and...
- The U.S. Department of Agriculture's Office of Administrative Services Procurement Management Branch awarded a delivery order to Lampire Biological Labs Inc. for Horse Blood/Defib 100 mls Vial (Catalog #7233401) on February 21, 2017. The contract, valued at $4,136.25 with a firm fixed-price structure, is designated as a Total Small Business Set Aside. This delivery order falls under the existing Blanket Purchase Agreement AG-3A94-C-12-0019 and was completed by the ultimate completion date of...
- <p>The Defense Health Agency awarded a purchase order to Lampire Biological Labs Inc. for $70,080 on April 1, 2022, for defibrinated rabbit blood in 50 milliliter units. The order carries no set-aside designation. Place of performance is Ottsville, Pennsylvania. The ceiling value is $70,080 under firm fixed pricing, with an ultimate completion date of March 31, 2027. The originating solicitation was a special notice posted February 7, 2022, with a due date of February 22, 2022.</p>
- The U.S. Department of Agriculture's Plains Area office awarded a $3,496 firm fixed-price purchase order to Lampire Biological Labs Inc. for sheep blood on December 18, 2018, with completion scheduled for December 31, 2019. This civilian contract, placed without set-aside designation, supports agricultural research activities at the Manhattan, Kansas location. Lampire Biological Labs Inc., a Pennsylvania-based manufacturer of animal-derived biological products, has served as a critical...
- The USDA Agricultural Research Service awarded a purchase order to Lampire Biological Labs Inc. on April 1, 2025, for $25,740.00 to supply sheep blood for research, set aside for total small business. The order calls for weekly deliveries of 100 milliliters of defibrinated sheep blood, drawn three days prior to shipment and tested quarterly for blue tongue, with animals verified as ivermectin-free for 30 days. Performance occurs in Pipersville, Pennsylvania, with delivery to the USDA Plains Area...
The Centers for Disease Control and Prevention Pittsburgh awarded a $1.537 million definitive firm fixed-price contract to Lampire Biological Labs Inc. for fresh turkey, chicken, guinea pig, and horse red blood cells on September 22, 2026, without set-aside. Place of performance is Ottsville, PA. The contract ceiling is $1,537,338 with an ultimate completion date of September 29, 2031. The requirement supports CDC's biological research and diagnostic operations through supply of animal-derived red blood cell materials.
Generated 9/11/26, 10:50 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $288.2k | 9/10/26 |